Substantiation of Using Pimecrolimus 1% Cream in Proactive Therapy of Children with Atopic Dermatitis
Atopic dermatitis (AtD) is multifactorial inflammatory skin disease with high prevalence in pediatric population. It is crucial to implement long-term maintenance therapy to prevent AtD exacerbations according to current clinical guidelines and expert reports. The article summarizes the results of t...
Main Authors: | Nikolay N. Murashkin, Roman A. Ivanov, Eduard T. Ambarchian, Roman V. Epishev, Alexander I. Materikin, Leonid A. Opryatin, Alena A. Savelova |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2021-11-01
|
Series: | Вопросы современной педиатрии |
Subjects: | |
Online Access: | https://vsp.spr-journal.ru/jour/article/view/2755 |
Similar Items
-
Pimecrolimus Efficacy and Safety in Management of Children with Atopic Dermatitis
by: Nikolay N. Murashkin, et al.
Published: (2024-11-01) -
Observational study of pimecrolimus 1% cream for prevention of transcutaneous sensitization in children with atopic dermatitis during their first year of life
by: Nikolay N. Murashkin, et al.
Published: (2023-04-01) -
PRINCIPLES THERAPY OF ATOPIC DERMATITIS IN CHILDHOOD IN THE ASPECT OF MODERN CONCEPTS OF THE PATHOGENESIS OF THE DISEASE
by: N. N. Murashkin, et al.
Published: (2017-10-01) -
Pimecrolimus for the Treatment of Atopic Dermatitis in Infants: An Asian Perspective
by: Chia-Yu Chu, et al.
Published: (2023-02-01) -
Modern Outlooks on «Atopic March» Secondary Prevention Capabilities in Children with Atopic Dermatitis
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01)